APA (7th ed.) Citation

C, S., CD, S., A, R., S, C., S, M., S, S., . . . HJ, S. (2025). Effectiveness, safety, and patient-reported outcomes of emtricitabine/tenofovir alafenamide-based regimens for the treatment of HIV-1 infection: Final 24-month results from the prospective German TAFNES cohort study. HIV medicine, 26(2), 239. https://doi.org/10.1111/hiv.13728

Chicago Style (17th ed.) Citation

C, Stephan, et al. "Effectiveness, Safety, and Patient-reported Outcomes of Emtricitabine/tenofovir Alafenamide-based Regimens for the Treatment of HIV-1 Infection: Final 24-month Results from the Prospective German TAFNES Cohort Study." HIV Medicine 26, no. 2 (2025): 239. https://doi.org/10.1111/hiv.13728.

MLA (9th ed.) Citation

C, Stephan, et al. "Effectiveness, Safety, and Patient-reported Outcomes of Emtricitabine/tenofovir Alafenamide-based Regimens for the Treatment of HIV-1 Infection: Final 24-month Results from the Prospective German TAFNES Cohort Study." HIV Medicine, vol. 26, no. 2, 2025, p. 239, https://doi.org/10.1111/hiv.13728.